[144] Nucor Corporation SEC Filing

Rhea-AI Filing Summary

Nucor (NUE) insider sale notice under Rule 144: This Form 144 shows an intended sale of 10,000 shares of Nucor common stock through Merrill Lynch on the NYSE, with an aggregate market value of $1,454,100.00 and an approximate sale date of 08/18/2025. The filing lists prior acquisitions of the shares as compensation (restricted stock vesting and performance shares) between 2013 and 2024, and discloses a recent sale on 06/26/2025 of 10,000 shares for gross proceeds of $1,303,708.80. The filer represents no undisclosed material adverse information about the issuer.

Positive

• Rule 144 compliance: The filing provides required disclosure for an insider sale, supporting regulatory transparency
• Source of shares disclosed: Shares were acquired via compensation (restricted stock vesting and performance shares), showing routine origin

Negative

• Insider selling: The filer intends to sell 10,000 shares valued at $1,454,100, which is a liquidity event by an insider
• Recent prior sale: The filer sold 10,000 shares on 06/26/2025 for $1,303,708.80, indicating ongoing disposals of holdings

Insights

Securities Analyst

TL;DR: Insiders intend to sell a modest block of 10,000 shares; transaction size is immaterial versus shares outstanding.

The filing reports a proposed sale of 10,000 shares valued at $1.45 million, against 229,535,447 shares outstanding, representing roughly 0.004% of the float by count. Shares were originally acquired as compensation (restricted stock and performance awards) across multiple years, indicating routine disposition of vested awards. A recent sale of 10,000 shares on 06/26/2025 for $1.3037 million is also disclosed. From a market-impact viewpoint this is unlikely to be material to Nucor's equity valuation, but it is relevant for monitoring insider liquidity and timing.

Corporate Governance Expert

TL;DR: Filing demonstrates compliance with Rule 144 and transparency around insider compensation-derived shares.

The Form 144 documents that the securities to be sold were acquired through company compensation programs (restricted stock vesting and performance shares) from 2013 through 2024. The notice includes the required representation that the seller has no undisclosed material adverse information. The disclosure and previous recent sale indicate routine insider liquidity events rather than governance concerns. Continued monitoring of insider trading cadence is prudent, but no governance red flags are evident from this filing alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 1301 Gervais St Suite 1500 Columbia SC 29201	10000	1454100.00	229535447	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/01/2024	Restricted Stock Vesting	Nucor Corporation			480	06/01/2024	Compensation
Common Stock	03/10/2024	Performance Shares	Nucor Corporation			6538	03/10/2024	Compensation
Common Stock	06/01/2014	Restricted Stock Vesting	Nucor Corporation			1008	06/01/2014	Compensation
Common Stock	03/10/2014	Performance Shares	Nucor Corporation			1050	03/10/2014	Compensation
Common Stock	06/03/2013	Restricted Stock Vesting	Nucor Corporation			149	06/03/2013	Compensation
Common Stock	03/11/2013	Performance Shares	Nucor Corporation			775	03/11/2013	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kenneth Rex Query 176 Whiting LN Georgetown SC 29440	Common Stock	06/26/2025	10000	1303708.80

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Nucor (NUE) report?

The Form 144 reports an intended sale of 10,000 Nucor common shares via Merrill Lynch on the NYSE with an aggregate market value of $1,454,100.00 and an approximate sale date of 08/18/2025.

How were the shares being sold acquired?

The filing shows the shares were acquired as compensation through restricted stock vesting and performance shares between 2013 and 2024 (examples: 480 shares on 06/01/2024; 6,538 shares on 03/10/2024).

Has the filer sold Nucor shares recently?

Yes. The filing discloses a sale on 06/26/2025 of 10,000 shares for gross proceeds of $1,303,708.80.

What percentage of outstanding shares does the proposed sale represent?

The filing lists 229,535,447 shares outstanding; the proposed sale of 10,000 shares is approximately 0.004% of that total (calculated from figures provided in the filing).

Does the filer declare any undisclosed material information about Nucor?

By signing the notice the filer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.